title: Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.
abstract: Clindamycin hydrochloride capsules (11 mg/kg body weight, q24 h) were administered orally to 20 dogs with deep staphylococcal pyoderma. Response to therapy was excellent in 100% of the dogs. Duration of therapy varied from 21 to 91 d, with an average duration of 45 d. Relapses occurred in 25% of the dogs within a 3-month period. One dog vomited when the clindamycin was given on an empty stomach. Under the conditions of the study, clindamycin was an effective, safe, and convenient antibiotic for the treatment of deep staphylococcal pyoderma in dogs.
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York 14853, USA.
authors.forename: D W
authors.initials: DW
authors.lastname: Scott
authors.forename: K E
authors.initials: KE
authors.lastname: Beningo
authors.forename: W H
authors.initials: WH
authors.lastname: Miller
authors.forename: E
authors.initials: E
authors.lastname: Rothstein
mesh_terms: D000284:Administration, Oral; D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D008297:Male; D011711:Pyoderma / Q000188:drug therapy / Q000662:veterinary*; D013203:Staphylococcal Infections / Q000150:complications / Q000188:drug therapy / Q000662:veterinary*
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002981:Clindamycin